Ultimate magazine theme for WordPress.

Heart transplants from severely obese donors show comparable outcomes for patients

DALLAS, Sept. 16, 2020 — Heart transplant patients who received hearts from severely obese donors had similar short-term outcomes and long-term survival as patients who received hearts from non-obese donors, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

The waiting list for a heart transplant in the U.S. is continuously about 3,000 people, and only half of those people receive a donor heart within a year. There is an urgent need to expand the pool of potential heart donors; however, transplant centers are hesitant to accept hearts from obese donors. In the U.S., almost 40% of the adult population is classified as obese, and nearly 8% have severe obesity, which is defined as a body mass index (BMI) greater than or equal to 40.

“As the prevalence of obesity in the U.S. continues to rise, it directly affects the pool of organ donors,” said Leora T. Yarboro, M.D., lead study author and associate professor of surgery at the University of Virginia in Charlottesville, Virginia. “Since the prevalence of severe obesity has increased significantly over the past 15 years, we wanted to investigate the outcomes of recipients of transplant hearts from donors with severe obesity.”

The study used the national United Network for Organ Sharing (UNOS) database to analyze the outcomes of 26,000 heart transplants from 2003-2017. Approximately 900, or 3.5%, of the donors had severe obesity. Severely obese donors, a BMI ?40, were more likely to be older and female. In addition:

  • 10% of severely obese donors had diabetes vs. 3% of non-obese donors;
  • 33% of obese donors had hypertension vs. 15% of donors with BMI 67% of heart transplants from severely obese donors were size mismatched (the donor’s weight was>130% of the recipient’s weight), compared to only 10% of transplants from donors without severe obesity; and
  • transplants from donors with severe obesity increased over time (from 2.2% in 2013 to 5.3% in 2017).

The analysis demonstrated no significant differences in post-transplant outcomes for patients who received a heart from a severely obese donor. Short-term outcomes, including postoperative stroke, acute rejection of the donor heart, pacemaker need and dialysis requirement, were similar for recipients of hearts from obese and non-obese donors. There was also no difference in one-year survival rates and long-term mortality for patients with transplants from severely obese donors.

“These findings were somewhat surprising because the severely obese donors did tend to have more medical problems, such as diabetes and high blood pressure, than the non-obese donors,” Yarboro said. “This study shows that with careful selection, hearts from obese donors can be used without an increased risk to the recipient. Given the continued increase in obesity in the U.S., this research has the potential to expand the critically low donor pool by increasing the number of donors and improving outcomes for the growing list of patients with end-stage heart failure.”

###

Co-authors Elizabeth D. Krebs, M.D., M.Sc.; Jared P. Beller, M.D.; J. Hunter Mehaffey, M.D., M.Sc.; Nicholas R. Teman, M.D.; Jamie L. W. Kennedy, M.D.; and Gorav Ailawadi, M.D. Author disclosures are in the manuscript.

The study was supported by the National Institutes of Health.

Additional Resources:

Available multimedia is on right column of release link – https://newsroom.heart.org/news/heart-transplants-from-severely-obese-donors-show-comparable-outcomes-for-patients?preview=238462d077290837fbf81f3e67fa32cb

After Sept. 16, view the manuscript online.

Heart transplants from donors with hepatitis C may be safe and could help decrease organ shortage

Women and men tolerate heart transplants equally well, but men may get better hearts

Follow AHA/ASA news on Twitter @HeartNews

Follow news from the AHA’s Circulation: Heart Failure journal @CircHF

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Source link